ZICCUM AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5 SEK | -3.85% |
|
-11.66% | -34.73% |
| 04-29 | Ziccum AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-14 | Ziccum AB Inhalable mRNA/LNP Project Confirms Excellent Properties Obtained by LaminarPace | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 7.6M | - | - | - | - | - | |
| 91.94B | ||||||
| 38.74B | ||||||
| 26.66B | ||||||
| 15.32B | ||||||
| 13.3B |
- Stock Market
- Equities
- ZICC Stock
- Charts Ziccum AB
- Sector Chart
